United States (US) Precision Oncology Market (2025-2031) | Analysis, Size & Revenue, Outlook, Companies, Trends, Industry, Segmentation, Growth, Forecast, Value, Competitive Landscape, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Precision Oncology Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Precision Oncology Market - Industry Life Cycle

3.4 United States (US) Precision Oncology Market - Porter's Five Forces

3.5 United States (US) Precision Oncology Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 United States (US) Precision Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.7 United States (US) Precision Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer cases in the United States

4.2.2 Technological advancements in precision oncology

4.2.3 Growing demand for personalized medicine in oncology treatment

4.3 Market Restraints

4.3.1 High cost associated with precision oncology treatments

4.3.2 Regulatory challenges and approval processes

4.3.3 Limited accessibility and adoption of precision oncology in certain regions

6.1 United States (US) Precision Oncology Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Precision Oncology Market Revenues & Volume, By Product Type, 2021- 2031F

6.1.3 United States (US) Precision Oncology Market Revenues & Volume, By Diagnostics, 2021- 2031F

6.1.4 United States (US) Precision Oncology Market Revenues & Volume, By Therapeutics, 2021- 2031F

6.2 United States (US) Precision Oncology Market, By Cancer Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Precision Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.2.3 United States (US) Precision Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.2.4 United States (US) Precision Oncology Market Revenues & Volume, By Cervical Cancer, 2021- 2031F

6.2.5 United States (US) Precision Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.2.6 United States (US) Precision Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.2.7 United States (US) Precision Oncology Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Precision Oncology Market, By End-use

6.3.1 Overview and Analysis

6.3.2 United States (US) Precision Oncology Market Revenues & Volume, By Hospitals & Diagnostic Laboratories, 2021- 2031F

6.3.3 United States (US) Precision Oncology Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F

6.3.4 United States (US) Precision Oncology Market Revenues & Volume, By Healthcare Data Companies, 2021- 2031F

7.1 United States (US) Precision Oncology Market Export to Major Countries

7.2 United States (US) Precision Oncology Market Imports from Major Countries

8.1 Average turnaround time for precision oncology testing

8.2 Patient satisfaction with personalized treatment plans

8.3 Number of clinical trials incorporating precision oncology approaches

8.4 Adoption rate of precision oncology tools and technologies

8.5 Success rate of targeted therapies in precision oncology treatments

9.1 United States (US) Precision Oncology Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 United States (US) Precision Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.3 United States (US) Precision Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 United States (US) Precision Oncology Market Revenue Share, By Companies, 2024

10.2 United States (US) Precision Oncology Market Competitive Benchmarking, By Operating and Technical Parameters